Home
Welcome
In conjunction with our Hospital partners, TTMI spearheads the integration of basic biomedical and clinical research focusing on Cancer, Genomics and Immunology to detect, diagnose and treat health conditions
Core Infrastructure
Project Highlights
- €4.8M investment in Trinity COVID-19 Immunology Research hub The Trinity COVID-19 Immunology Research hub seeks to utilize its world-class immunology expertise to provide research-based solutions to tackle the COVID-19 pandemic
- €10.5M programme to develop next generation cell therapies for cancer Researchers at TTMI are part of a successful consortium to secure €6.8M government funding as part of a 3-year, €10.5M programme to develop next generation cell therapies for cancer.
- €7.2M programme to deliver next generation gene therapies for gastrointestinal cancer TTMI researchers are part of a successful consortiuma planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer